From: Endotracheal tube microbiome in hospitalized patients defined largely by hospital environment
Location | |||
---|---|---|---|
ICU-1 (n = 73) | ICU-2 (n = 42) | ||
Age | |||
Mean ± SD | 64 ± 14 | 67 ± 18,87 | |
Intubation days | |||
Median (quartile 1, quartile 3) | 6 (4, 10) | 4.5 (3, 8) | |
Sex | n (%) | n (%) | |
Male | 43 (58.9) | 19 (45.2) | |
Female | 30 (41.0) | 23 (54.7) | |
Population characteristics | |||
Oncological background | 22 (30.1) | 7 (16.66) | |
Transplant | 2 (2.73) | 1 (2.38) | |
Use of steroids | 5 (6.84) | 4 (9.52) | |
Previous hospital stay | 40 (54.7) | 17 (40.47) | |
VAP | 18 (24.6) | 5 (11.90) | |
Extubation reason | |||
Recovery | 28 (38.35) | 28 (66.66) | |
Death | 36 (49.31) | 6 (14.28) | |
Tracheostomy | 9 (12.32) | 8 (19.04) | |
Intubation length of stay (grouped by days) | |||
Long (> 16 days) | 6 (8.22) | 0 (0) | |
Middle (6–15 days) | 31 (42.46) | 17 (40.47) | |
Short (0–5 days) | 36 (49.31) | 25 (59.52) | |
Hospital antibiotic use | p value* | ||
Previous antibiotic use | 45 (61.64) | 16 (38.09) | 0.024 |
Antibiotic during intubation time | 63 (86.30) | 29 (69.04) | 0.047 |
Use of beta-lactams | 58 (79.45) | 22 (52.38) | < 0.001 |
Use of glycopeptides | 11 (15.06) | 7 (16.66) | 0.80 |